Which Patinets Benefit More From Percutaneous Nephrolithotomy? A Location-Based Comparative Analysis of PCNL and RIRS for 1-2 cm Renal Stones
연구 개요
상태
상세 설명
n this prospective randomized controlled trial, 110 adult patients diagnosed with a single non-staghorn renal stone measuring 10-20 mm were enrolled. The study was conducted at Kırıkkale High Specialization Hospital between the specified study dates. Participants were randomized in a 1:1 ratio into two treatment arms: Percutaneous Nephrolithotomy (PCNL) and Retrograde Intrarenal Surgery (RIRS). Randomization was implemented using a computer-generated sequence to ensure unbiased allocation.
The primary objective is to compare the stone-free rates (SFR) between the two surgical techniques at the 3-month postoperative mark, as confirmed by non-contrast computed tomography. A secondary and key focus of the study is the impact of stone localization (upper, middle, and lower calyx) on the success of each procedure. Additional outcomes evaluated include total operative time, hospital stay duration, hemoglobin level changes, and postoperative complication rates according to the Clavien-Dindo classification system. The results aim to provide a location-based surgical selection framework for mid-sized renal stones.
연구 유형
등록 (실제)
단계
- 해당 없음
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
Patients aged 18 years or older. Presence of a single, non-staghorn radiopaque renal stone measuring 10-20 mm in diameter.
Stone location in the upper, middle, or lower renal calyx. Patients who provided written informed consent.
Exclusion Criteria:
Patients with untreated urinary tract infections or urosepsis. Patients with uncorrected bleeding disorders or receiving anticoagulant therapy.
Presence of severe skeletal deformities preventing surgical positioning. Patients with morbid obesity (BMI > 40 kg/m²). Presence of anatomical abnormalities (e.g., horseshoe kidney, ectopic kidney). Pregnancy. Multiple renal stones or stones larger than 20 mm
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: PCNL Group
Patients in this group underwent Percutaneous Nephrolithotomy (PCNL) for the treatment of renal stones measuring 10-20 mm.
The procedure was performed in the prone or lithotomy position under general anesthesia.
|
A standard percutaneous approach was used.
Under general anesthesia, a nephrostomy tract was established, and the stone was fragmented using a pneumatic or ultrasonic lithotripter.
|
|
활성 비교기: RIRS Group
Patients in this group underwent Retrograde Intrarenal Surgery (RIRS) using a flexible ureterorenoscope and laser lithotripsy for the treatment of renal stones measuring 10-20 mm.
|
The procedure was performed using a flexible ureterorenoscope.
Stones were fragmented using a Holmium:YAG laser fiber after reaching the renal pelvis and calyces retrogradely.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Stone-Free Rate (SFR)
기간: 3 months postoperatively
|
The percentage of patients who are completely free of stones or have only clinically insignificant residual fragments (less than 3 mm).
This will be evaluated using non-contrast computed tomography (NCCT)
|
3 months postoperatively
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Total Operative Duration
기간: During the surgical procedure (intraoperative)
|
The time from the initial incision or insertion of the endoscope until the completion of the procedure and dressing, measured in minutes
|
During the surgical procedure (intraoperative)
|
|
Change in Hemoglobin Levels
기간: Within 24 hours postoperatively.
|
The difference between preoperative and postoperative hemoglobin levels to assess blood loss.
|
Within 24 hours postoperatively.
|
|
Postoperative Complications
기간: From surgery up to 30 days postoperatively.
|
The frequency and severity of complications classified according to the Clavien-Dindo classification system
|
From surgery up to 30 days postoperatively.
|
|
Length of Hospital Stay
기간: From the day of surgery until hospital discharge (typically 1-3 days).
|
The total number of days the patient remained in the hospital following the procedure.
|
From the day of surgery until hospital discharge (typically 1-3 days).
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 12/14-06
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Percutaneous Nephrolithotomy (PCNL)에 대한 임상 시험
-
The First Affiliated Hospital of Guangzhou Medical...Massachusetts General Hospital; University College London Hospitals; University of Belgrade; Vancouver General Hospital 그리고 다른 협력자들알려지지 않은수술 | 결석, 신장 | 신장 결석증
-
The First Affiliated Hospital of Guangzhou Medical...아직 모집하지 않음
-
Mahidol University아직 모집하지 않음
-
Foundation EndourologyThe International Alliance of Urolithiasis모병
-
The Cleveland ClinicMassachusetts General Hospital; University of British Columbia; Columbia University; Duke University 그리고 다른 협력자들완전한
-
Mansoura University알려지지 않은